白细胞介素-1 受体相关激酶 (IRAK) 是丝氨酸/苏氨酸激酶,通过其在 Toll 样受体 (TLR) 和白细胞介素 1 受体 (IL-1R) 介导的信号通路中的作用,在启动针对外来病原体和其他类型危险的先天免疫反应中发挥关键作用。已鉴定出四种不同的 IRAK 样分子:两种活性激酶 IRAK-1 和 IRAK-4,以及两种非活性激酶 IRAK-2 和 IRAK-M。所有 IRAK 均介导核因子 κB (NF-κB) 和丝裂原活化蛋白激酶 (MAPK) 通路的激活。
Toll 样受体通过接头分子 MyD88 和 IL-1R 相关激酶家族成员 (IRAK-1、2、M 和 4) 传递信号。IRAK-1 和 IRAK-2 已知能与 MyD88-IRAK-4 形成 Myddosome,介导 TLR7 诱导的 TAK1 依赖性 NF-κB 激活。IRAK-M 已知能作为负调节剂发挥作用,防止 IRAK 与 MyD88 分离,从而抑制下游信号传导。
Interleukin-1 receptor-associated kinases (IRAKs), are serine/threonine kinases, play critical roles in initiating innate immune responses against foreign pathogens and other types of dangers through their role in Toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) mediated signaling pathways. The four different IRAK-like molecules have been identified: two active kinases, IRAK-1 and IRAK-4, and two inactive kinases, IRAK-2 and IRAK-M. All IRAKs mediate activation of nuclear factor-kappaB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways.
Toll-like receptors transduce their signals through the adaptor molecule MyD88 and members of the IL-1R-associated kinase family (IRAK-1, 2, M and 4). IRAK-1 and IRAK-2, known to form Myddosomes with MyD88-IRAK-4, mediate TLR7-induced TAK1-dependent NF-κB activation. IRAK-M is known to function as a negative regulator that prevents the dissociation of IRAKs from MyD88, thereby inhibiting downstream signalling.
IRAK inhibitor 3 是一种白细胞介素-1受体相关激酶 (IRAK) 调节剂,详细信息请参考专利 WO 2008030579 A2。
IRAK4 modulator-1(实施例161)是一种IRAK4调节剂,其IC50=4.647 μM,可用于研究IRAK介导的病症。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号